Iovance Biotherapeutics Inc (IOVA)
11.66
+0.20
(+1.70%)
USD |
NASDAQ |
Nov 05, 16:00
11.66
0.00 (0.00%)
After-Hours: 16:04
Iovance Biotherapeutics Revenue (Quarterly): 31.11M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 31.11M |
March 31, 2024 | 0.715M |
December 31, 2023 | 0.482M |
Date | Value |
---|---|
September 30, 2023 | 0.469M |
June 30, 2023 | 0.238M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.238M
Minimum
Jun 2023
31.11M
Maximum
Jun 2024
6.602M
Average
0.482M
Median
Dec 2023
Revenue (Quarterly) Benchmarks
Perspective Therapeutics Inc | -- |
Electromed Inc | 14.83M |
Xtant Medical Holdings Inc | 29.94M |
Myomo Inc | 7.521M |
Catheter Precision Inc | 0.093M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -97.10M |
Total Expenses (Quarterly) | 133.02M |
EPS Diluted (Quarterly) | -0.34 |
Enterprise Value | 3.067B |
Gross Profit Margin (Quarterly) | -0.84% |
Profit Margin (Quarterly) | -312.2% |
Earnings Yield | -14.33% |
Normalized Earnings Yield | -14.33 |